• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Home
  • LinkedIn
  • Twitter

  • About Us
    • Overview
    • Executive Committee
    • Board Of Directors
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • Our Technology
      • TIM
      • shRNA
      • shARC Platform
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Careers
  • Contact Us

Celyad to Participate in Upcoming September 2019 Conferences

August 29, 2019 By Celyad

Mont-Saint-Guibert, Belgium – Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management plans to participate at the following events in September 2019:

Wells Fargo Healthcare Conference

Date:  Wednesday, September 4, 2019              

Presentation Time:  4:10 p.m. EDT

Location:  Boston, Massachusetts, USA

Webcast:  Celyad’s website, under Events & Webcasts section 

CAR-TCR Summit

Date:  September 10 – 13, 2019            

Location:  Boston, Massachusetts, USA 

International Conference on Lymphocyte Engineering (ICLE)

Date:  September 13 – 15, 2019           

 Location:  London, United Kingdom 

KBC Annual Healthcare Conference

Date:  Thursday, September 26, 2019Location:  Brussels, Belgium

Download press release(s)
Communiqué de presse
Press Release

Filed Under: Corporate, Non-regulated

Footer

Celyad Oncology

Celyad Oncology Logo
  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.

  • Cookie Policy |
  • Privacy Policy |
  • Terms of Use